期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

抗血管内皮生长因子单克隆抗体Bevacizumab玻璃体腔注射后眼内炎一例 被引量：4

原文传递
导出
摘要 患者女，67岁。因右眼视力下降、视物变形就诊。否认糖尿病病史。经眼科常规检查和眼底检查后诊断为右眼老年性黄斑变性（AMD）。
作者 许宇 黄欣 赵培泉 王文吉
机构地区 复旦大学附属眼耳鼻喉科医院眼科
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2008年第3期225-226,共2页 Chinese Journal of Ocular Fundus Diseases
关键词 黄斑变性/药物疗法 眼内炎/病因学 抗体 单克降/治疗应用 BEVACIZUMAB
分类号 R774.5 [医药卫生—眼科]
  • 相关文献

参考文献11

  • 1Speaker MG, Milch FA, Shah MK, et al. Role of external haeterial flora in the pathogenesis of aeute postoperative endophthalmitis. Ophthalmology, 1991, 98:639-650.
  • 2Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol, 1996, 122: 1-17.
  • 3Bannerman TL, Rhoden DL, McAllister SK, et al. The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study:a comparison of eyelid and intraocular isolates using pulse-field gel electrophoresis. Arch Ophthalmol, 1997, 115:357-361.
  • 4Jonas JB, Kreissig I, Degenring R. Intravitreal triameinolone acetonide for treatment of intraocular proliferative, exudative and neovaseular disease. Prog Retin Eye Res, 2005,24: 587- 611.
  • 5Mor F, Quintana FJ, Cohen IR. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Thl polarization. J Immunol, 2004,172 : 4618-4623.
  • 6Fung AE, Rosenfeld P J, Reiehel E. The inernational intravitreal bevaeizumab safety survey: Using the internet to assess drug safety worldwide. Br J Ophthalmol,2006,90: 1344- 1349.
  • 7叶存喜,马景学,张斌,黄灵欣.眼内炎的分级标准和临床意义[J].中国实用眼科杂志,2005,23(4):401-402. 被引量：12
  • 8Cottingham A J, Forster RK. Vitrectomy in endophthalmitis. Arch Ophthalmol, 1976, 94: 2078-2081.
  • 9Stern GA, Engel HM, Driebe NT. Thetreatment of postoperative endophthalmitis. Ophthalmology, 1989,96: 62- 67.
  • 10Dolt BH, Weiskopf J, Nilsson-Ehle I. Amphotericin clearance in vitrectomized versus nonvitrectomized eyes. Ophthalmology, 1985,92: 1601-1605.

二级参考文献4

  • 1Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis vitrecomy study: a randomized trial of immedite vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch ophthalmol, 1995, 113:1479-1496.
  • 2林锦镛.葡萄膜炎的病理特点[A].孙为荣主编.眼科病理学[C].北京:人民卫生出版社,1997.205-224.
  • 3王廉曾,华白钢,吴奇志,王晓洁,梁军.玻璃体切割手术治疗化脓性眼内炎[J].中国实用眼科杂志,1997,15(10):632-634. 被引量：6
  • 4陈钦元,王文吉,戴为英.玻璃体切割术治疗感染性眼内容炎[J].实用眼科杂志,1992,10(10):591-593. 被引量：13

共引文献11

同被引文献66

  • 1夏伟丹,刘晓玲,李英姿.玻璃体腔内注射的护理配合[J].现代中西医结合杂志,2007,16(3):403-403. 被引量：8
  • 2Falkenstein IA,Cheng L,Freeman WR.Changes of intraocular pressure after intravitreal injection of bevacizumab(avastin)[J].Retina,2007,27:1044-1047.
  • 3Pegaptanib:new drug.In macular degeneration:too many risks for too little benefit[editorial].Prescrire Int,2006,15:127-129.
  • 4Bakri SJ,McCannel CA,Edwards AO,et al.Persistent ocular hypertension following intravitreal ranibizumab[J].Graefe's Arch Clin Exp Ophthalmol,2008,246:955-958.
  • 5Singh RP,Kaiser PK.Role of ranibizumab in management of macular degeneration[J].Indian J Ophthalmol,2007,55:421-425.
  • 6Utman SA,Dhillon B.Re:Changes of intraocular pressure after intravitreal injection of bevacizumab(Avastin)[J].Retina,2008,28:667-668.
  • 7Garg S,Brod R,Kim D,et al.Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration[J].Clin Exp Ophthalmol,2008,36:252-256.
  • 8Chang LK,Sarraf D.Tears of the retinal pigment epithelium:an old problem in a new era[J].Retina,2007,27:523-534.
  • 9Chan CK,Meyer CH,Gross JG,et al.Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration[J].Retina,2007,27:541-551.
  • 10Kook D,Wolf A,Neubauer AS,et al.Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD.Frequency and progress[J].Ophthalmologe,2008,105:158-164.

引证文献4

二级引证文献10

中华眼底病杂志
2008年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部